{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:00:33Z","timestamp":1761919233766},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T00:00:00Z","timestamp":1244678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s10067-009-1208-x","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T11:51:38Z","timestamp":1244634698000},"page":"1217-1220","source":"Crossref","is-referenced-by-count":24,"title":["Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients?"],"prefix":"10.1007","volume":"28","author":[{"given":"Raquel","family":"Cuchacovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis R.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,11]]},"reference":[{"key":"1208_CR1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.atherosclerosis.2007.01.004","volume":"196","author":"CP Chung","year":"2007","unstructured":"Chung CP, Oeser A, Solus JF et al (2007) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196:756\u2013763","journal-title":"Atherosclerosis"},{"key":"1208_CR2","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID Rincon Del","year":"2002","unstructured":"Del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A (2002) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737\u20132745","journal-title":"Arthritis Rheum"},{"key":"1208_CR3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","volume":"48","author":"C Popa","year":"2007","unstructured":"Popa C, Netea M, van Riel P et al (2007) The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 48:751\u2013761","journal-title":"J Lipid Res"},{"key":"1208_CR4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/ard.2004.026534","volume":"64","author":"DN Kiortsis","year":"2005","unstructured":"Kiortsis DN, Mavridis AK, Vasakos S et al (2005) Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 64:765\u2013766","journal-title":"Ann Rheum Dis"},{"key":"1208_CR5","first-page":"83","volume":"24","author":"MA Gonzalez-Gay","year":"2006","unstructured":"Gonzalez-Gay MA, DeMatias JM, Gonzalez-Juanatey C et al (2006) Anti-tumor necrosis factor alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 24:83\u201386","journal-title":"Clin Exp Rheumatol"},{"key":"1208_CR6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s10067-007-0702-2","volume":"26","author":"B Seriolo","year":"2007","unstructured":"Seriolo B, Paolino S, Ferrone C et al (2007) Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatopid arthritis. Clin Rheumatol 26:1799\u20131800","journal-title":"Clin Rheumatol"},{"key":"1208_CR7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","volume":"26","author":"LS Tam","year":"2007","unstructured":"Tam LS, Tomlinson B, Chu T et al (2007) Impact of TNF inhibition on insulin resistance and lipid levels in patients with rheumatoid arthritis. Clin Rheumatol 26:1495\u20131498","journal-title":"Clin Rheumatol"},{"key":"1208_CR8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1179\/acb.2007.035","volume":"62","author":"FM Oguz","year":"2007","unstructured":"Oguz FM, Oguz A, Uzunlulu M (2007) The effect of infliximab treatment on insulin resistance in patients with rheumatoid arthritis. Acta Clin Belg 62:218\u2013222","journal-title":"Acta Clin Belg"},{"key":"1208_CR9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1517\/14656566.3.7.845","volume":"3","author":"V Saravanan","year":"2002","unstructured":"Saravanan V, Hamilton J (2002) Advances in the treatment of rheumatoid arthritis: old versus new therapies. Expert Opin Pharmacother 3:845\u2013856","journal-title":"Expert Opin Pharmacother"},{"key":"1208_CR10","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","volume":"8","author":"VP Halm van","year":"2006","unstructured":"van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE (2006) Disease modifying drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8:R151","journal-title":"Arthritis Res Ther"},{"key":"1208_CR11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"HK Choi","year":"2002","unstructured":"Choi HK, Heman MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173\u20131177","journal-title":"Lancet"},{"key":"1208_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/03009740500474578","volume":"35","author":"SR Dahqvist","year":"2006","unstructured":"Dahqvist SR, Engstrand S, Berglin E, Johnson O (2006) Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy. Scand J Rheumatol 35:107\u2013111","journal-title":"Scand J Rheumatol"},{"key":"1208_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/03009740601179605","volume":"36","author":"A Rosenvinge","year":"2007","unstructured":"Rosenvinge A, Krogh-Madsen R, Baslund B, Pedersen BK (2007) Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNF alpha therapy. Scand J Rheumatol 36:91\u201396","journal-title":"Scand J Rheumatol"},{"key":"1208_CR14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/ard.2006.066191","volume":"66","author":"C Popa","year":"2007","unstructured":"Popa C, van den Hoogen FH, Radstake TR et al (2007) Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis 66:1503\u20131507","journal-title":"Ann Rheum Dis"},{"key":"1208_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2310\/6650.2007.06013","volume":"55","author":"MP Reilly","year":"2007","unstructured":"Reilly MP, Rohatgi A, McMahon K et al (2007) Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. J Invest Med 55:26\u201335","journal-title":"J Invest Med"},{"key":"1208_CR16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1601","volume":"13","author":"J Sun","year":"2007","unstructured":"Sun J, Sukhova GK, Wolters PJ et al (2007) Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13:719\u2013724","journal-title":"Nat Med"},{"key":"1208_CR17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/art.24350","volume":"60","author":"EW Karlson","year":"2009","unstructured":"Karlson EW, Chibnik LR, Tworogner SS et al (2009) Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum 60:641\u2013652","journal-title":"Arthritis Rheum"},{"key":"1208_CR18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.bbrc.2006.02.087","volume":"342","author":"RS Kota","year":"2006","unstructured":"Kota RS, Rutledge JC, Gohil K et al (2006) Regulation of gene expression in RAW 264.7 macrophage cell line by interferon-gamma. Biochem Biophys Res Commun 342:1137\u20131146","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1208-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1208-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1208-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:36Z","timestamp":1559105496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1208-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,11]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1208-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,11]]}}}